TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bioteria Technologies AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
11,849
|
9,578
|
8,560 |
| Financial expenses |
192
|
123
|
16 |
| Earnings before taxes |
-1,339
|
-819
|
336 |
| EBITDA |
-449
|
-76
|
784 |
| Total assets |
8,295
|
8,373
|
4,732 |
| Current assets |
3,429
|
3,191
|
3,622 |
| Current liabilities |
5,050
|
5,805
|
2,672 |
| Equity capital |
680
|
1,026
|
1,917 |
| - share capital |
44
|
45
|
45 |
| Employees (average) |
60
|
63
|
56 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
8.2%
|
12.3%
|
40.5% |
| Turnover per employee |
197
|
152
|
153 |
| Profit as a percentage of turnover |
-11.3%
|
-8.6%
|
3.9% |
| Return on assets (ROA) |
-13.8%
|
-8.3%
|
7.4% |
| Current ratio |
67.9%
|
55.0%
|
135.6% |
| Return on equity (ROE) |
-196.9%
|
-79.8%
|
17.5% |
| Change turnover |
2,596
|
994
|
1,346 |
| Change turnover % |
28%
|
12%
|
19% |
| Chg. No. of employees |
-3
|
7
|
15 |
| Chg. No. of employees % |
-5%
|
13%
|
37% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.